IMC-C103C

Genentech to pay Immunocore $100M to co-develop preclinical MAGE-A4 drug
Fierce Biotech
Mon, 11/19/18 - 09:54 am
Genentech
Roche
MAGE-A4
IMC-C103C
Immunocore